Filing Details
- Accession Number:
- 0001144204-17-063792
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-14 20:18:08
- Reporting Period:
- 2017-11-29
- Accepted Time:
- 2017-12-14 20:18:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1429260 | Fortress Biotech Inc. | FBIO | Pharmaceutical Preparations (2834) | 205157386 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1578699 | George Avgerinos | C/O Fortress Biotech, Inc. 2 Gansevoort Street, 9Th Floor New York NY 10014 | Svp, Biologics Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 | Acquisiton | 2017-11-29 | 150,000 | $0.00 | 409,088 | No | 4 | A | Direct | |
| Common Stock, Par Value $0.001 | Disposition | 2017-12-12 | 25,593 | $3.59 | 383,495 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.001 | Disposition | 2017-12-13 | 19,000 | $3.57 | 364,495 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents shares of common stock issued to the Reporting Person upon the partial vesting of an award of restricted stock units initially made on July 15, 2015.
- Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the sale transactions on December 12, 2017, was $3.53 to $3.72, and the range of prices for the sale transactions on December 13, 2017, was $3.55 to $3.63. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
